title: [Tolazoline and dopamine in the treatment of the persistent fetal circulation syndrome].
abstract: The combined application of Tolazoline and Dopamine for the treatment of the persistent fetal circulation syndrome showed that Dopamine prevented the most common side effects of Tolazoline i.e. systemic hypotension and oliguria. The authors emphasize the importance of continuous monitoring of the systemic blood pressure in infants during this treatment.
mesh_terms: D004298:Dopamine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D007231:Infant, Newborn; D008297:Male; D009846:Oliguria / Q000139:chemically induced / Q000517:prevention & control; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*; D014043:Tolazoline / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014043:Tolazoline; D004298:Dopamine
vernacular_title: Tolazoline und Dopamin bei der Behandlung des persistierenden fetalen Zirkulationssyndroms.